Le Lézard

News by subject: TRI

1 2 3 4 5 6 7 8 9 10

Today

16:11
Neovasc, Inc. ("Neovasc" or the "Company") , a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today...

13:47
Morris Animal Foundation-funded researchers at the University of Illinois identified a new fungus that could be a significant emerging pathogen of freshwater turtles. The new genus and species, Emydomyces testavorans, has been found in the shell...

12:30
Significant advances in the global search for blood test technologies for Alzheimer's disease and other dementias were reported at the Alzheimer's Association International Conference (AAIC) 2019 in Los Angeles. A new...

11:00
New research reported at the Alzheimer's Association International Conference (AAIC) 2019 in Los Angeles evaluates drug and non-drug treatments to improve sleep patterns in persons with Alzheimer's disease or other dementias. Sleep disruption is a...

10:00
Bayer announced today the U.S. Food and Drug Administration (FDA) has approved Gadavist® (gadobutrol) injection for use in cardiac magnetic resonance (MR) imaging to assess myocardial perfusion (stress, rest) and late gadolinium enhancement in adult...

09:02
Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure, today announced enrollment of the first patient in its prospective, multi-center, SIRONA II trial, in Europe. The 60-patient...

08:30
Neurotrope Inc. , a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative diseases, including Alzheimer's disease (AD), today announced that the Company has concluded data collection in its confirmatory Phase 2...

08:30
Seqirus is first to begin shipping its portfolio of seasonal influenza vaccines for the upcoming 2019/20 U.S. influenza season Seqirus plans to distribute more than 50 million doses of influenza vaccines to healthcare providers across the U.S....

08:00
Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., one of the world's leading companies in the diagnostic imaging business, shares the results of a new prospective clinical study of the use of ultrasound enhancing agents (UEAs) in...

08:00
Soliton, Inc., ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced additional...

07:30
Biohaven Pharmaceutical Holding Company Ltd. announces that The Lancet published online positive results from a Phase 3 pivotal clinical trial of rimegepant Zydis® orally dissolving tablet (ODT) for the acute treatment of migraine. These data show...

07:00
Alkermes plc today provided an update on its regulatory strategy for ALKS 3831 (olanzapine/samidorphan), the company's investigational, novel, once-daily, oral atypical antipsychotic drug candidate designed to provide the efficacy of olanzapine...

00:09
Researchers at Okayama University have developed an early gastric cancer endoscopic diagnosis system using artificial intelligence (AI). The details were presented at the Congress of the Japan Gastroenterological Endoscopy Society (JGES), May 31 ?...


14 july 2019

19:00
Ascentage Pharma, a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, hepatitis B virus and age-related diseases, today announced that the company recently dosed the first patient successfully...


13 july 2019

06:05
I-Mab Biopharma ("I-Mab"), a clinical stage biotech company exclusively focusing on discovery and development of innovative biologics in immuno-oncology and autoimmune diseases, announces that the National Medical Products Administration (NMPA) has...


12 july 2019

11:59
Halozyme Therapeutics, Inc. , a biotechnology company developing novel oncology and drug-delivery therapies, today announced that its collaborator Janssen Biotech, Inc. (Janssen) has submitted a Biologics License Application (BLA) to the U.S. Food...

09:00
With the majority of 510(k) submissions having major deficiencies or being rejected the first time, scientific and regulatory experts TSG Consulting recommend that manufacturers schedule a Pre-Submission (Pre-Sub) meeting with the FDA to improve the...

07:00
EIP Pharma, Inc., a CNS-focused therapeutics company, today announced the initiation of a new Phase 2 proof-of-concept study evaluating neflamapimod as a treatment for the cognitive dysfunction associated with dementia with Lewy bodies (DLB). The...

06:45
Eli Lilly and Company today announced the presentation of post-hoc analyses showing improvements in daily functioning and reductions in disability in patients with chronic and episodic migraine treated with Emgality® (galcanezumab-gnlm) compared to...

04:28
Cyxone (publ.) a Swedish biotech in autoimmune diseases, today announced that the first healthy male volunteer has received the initial dose in its first-in-human, clinical phase I, trial with drug candidate T20K, in development for the treatment of...


11 july 2019

16:30
Amgen , Novartis and Banner Alzheimer's Institute today announced the collective decision to discontinue investigation of the BACE1 inhibitor CNP520 (umibecestat) in two pivotal Phase 2/3 studies in the Alzheimer's Prevention Initiative Generation...

14:02
In the news release, New Data in 2 Oral and 13 Poster Presentations about Eisai's Latest Dementia Pipeline, Including BAN2401, Elenbecestat and Lemborexant, to be Presented at Alzheimer's Association International Conference, issued July 11, 2019 by...

13:00
rHEALTH LLC, and its affiliate DNA Medicine Institute, Inc., today announced that both of its abstracts have been accepted via peer-review from for the 2019 American Association of Clinical Chemistry (AACC) meeting. The titles and details of the...

13:00
Meril's recently CE-approved MeRes100, used for the treatment of de-novo coronary artery lesions, has demonstrated zero scaffold thrombosis and very low Major Adverse Cardiac Event (MACE) rate of 1.87% at three years as shown in MeRes-1 and 1.61% in...

12:50
Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., announced today that two oral and 13 poster presentations about its Alzheimer's Disease (AD), dementia pipeline will be presented at the 2019 Alzheimer's Association International...

10:00
Portage Biotech Inc., ("Portage" or the "Company")  today announced it has entered in an agreement with Fast Forward Innovations Limited (AIM Market: FFWD) ("Fast Forward") to purchase Intensity Holdings Limited ("IHL"), a wholly-owned subsidiary of...

09:48
Acutus Medical today announced the publication of the UNCOVER AF study in Circulation: Arrhythmia and Electrophysiology. The study demonstrated 73 percent single-procedure freedom from atrial fibrillation (AF) at 12 months with the use of Acutus'...

09:00
Spartan Bioscience, creator of the world's first on-site Legionella DNA test, today announced a partnership with LiquiTech, a leader in Legionella prevention for the health care, commercial, and hospitality industries. Through this strategic...

08:55
Nordic Nanovector ASA (OSE: NANO) announces that the final patient has been enrolled in the LYMRIT 37-05 clinical trial of Betalutin® (177Lu-satetraxetan-lilotomab) in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) not...

08:30
Enteris BioPharma, Inc., a biotechnology company developing innovative drug products built around its proprietary delivery technologies, congratulates Cara Therapeutics on the successful initiation of its Phase 2 clinical trial of Oral KORSUVAtm...

08:30
Neurotrope, Inc. , a clinical- stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases, including Alzheimer's disease ("AD") is announcing that Dr. Daniel L. Alkon, the Company's President and CSO, will be honored...

08:02
DiamiR, a developer of innovative blood-based diagnostic tests for neurological and other diseases, announced today the publication of "Brain-enriched microRNAs circulating in plasma as novel biomarkers for Rett syndrome" in PLOS ONE...

08:00
Actinium Pharmaceuticals, Inc.  ("Actinium") today highlighted its presence at the Health Physics Society ("HPS") 64th Annual Meeting that is being held July 7th ? 11th in Orlando, Florida. During HPS, Actinium presented the findings of two studies...

07:30
Biohaven Pharmaceutical Holding Company Ltd. , today announced it will present 16 scientific presentations (oral and poster) highlighting new efficacy and safety data for rimegepant from Biohaven's robust clinical development program at the American...

07:00
Smith & Nephew , the global medical technology business, today announces the results of the first ever prospective clinical trial to evaluate the effectiveness of repairing Horizontal Cleavage Tears (HCTs), one of the most common meniscal tears...

06:45
Eli Lilly and Company announced today that the New England Journal of Medicine published positive Phase 3 study results of Emgality® (galcanezumab-gnlm) for the treatment of episodic cluster headache.1 In this study, Emgality reduced the frequency...

06:00
IDEAYA Biosciences, Inc., an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics to treat cancer, announces initiation of its Phase 1/2 study evaluating IDE196 in Patients with Solid Tumors...


10 july 2019

20:00
Theodoros Zanos, PhD, head of the Neural & Data Science Lab & assistant professor at the Institute of Bioelectronic Medicine, The Feinstein Institutes for Medical Research, and his collaborators, discovered how the vagus nerve relays signals from the...

17:00
Biohaven Pharmaceutical Holding Company Ltd. , announced today that positive results from a Phase 3 pivotal clinical trial of rimegepant, Biohaven's small molecule calcitonin gene-related peptide (CGRP) receptor antagonist, for the acute treatment of...

17:00
A drug belonging to a new generation of acute migraine headache treatments was found to eliminate pain and reduce bothersome symptoms for people with migraine in a large-scale trial reported in the July 11 issue of The New England Journal of...

15:00
Three Charlotte hand surgeons have discovered that people of any age born without a hand already have the functionality needed to control a prosthetic device using only their mind. The breakthrough research, led by Drs. Michael Gart , Bryan Loeffler...

14:15
Eli Lilly and Company today announced the upcoming presentation of data indicating rising rates of opioid use for the treatment of migraine based on results from the OVERCOME (Observational Survey of the Epidemiology, Treatment and Care of Migraine)...

12:08
The Alzheimer's Drug Discovery Foundation (ADDF) released a new clinical trial analysis report that shows researchers are now developing drugs for various targets associated with aging biology ? moving beyond traditional amyloid and tau approaches....

10:00
Natreon announces the results of the recently published randomized, double-blind, placebo controlled clinical study from Ohio State University Wexner Medical Center for PrimaVie®, its patented shilajit extract. PrimaVie® is an organic humic substance...

09:00
Clover Health today launched Clover Therapeutics, a research subsidiary focused on developing medicines for older adults. Clover Therapeutics also announced it entered into a research collaboration and license agreement with Genentech, a member of...

08:37
Biomarck Pharmaceuticals, Ltd today announced that statistical significance (p=0.02) was achieved in improvement of Overall Response Rate (ORR) in the BIO-11006/SOC group compared to standard of care alone at 3 months in the Phase 2 study in NSCLC....

08:05
Respicardia, Inc., the manufacturer of the only FDA-approved active implantable device for the treatment of central sleep apnea (CSA), today announced the publication of the 24- and 36-month data from the remed?® System Pivotal Trial in the...

08:00
TARIS Biotm today announced the dosing of the first patient in a Phase 1b clinical trial evaluating the investigational product TAR-200 in combination with Opdivo® (nivolumab), a programmed death-1 (PD-1) immune checkpoint inhibitor from...

08:00
Geneos Therapeutics, a clinical-stage biotech company, a spin-out of Inovio Pharmaceuticals , announced today that the first cancer patient was dosed using the company's GT-EPIC Neoantigen-Targeting Personalized Vaccine Technology. In this...

08:00
DiscGenics, Inc., a clinical stage biotechnology company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced the first Utahns have been...

1 2 3 4 5 6 7 8 9 10